Ataraxis AI

Ataraxis AI is an AI precision medicine company focused on transforming patient outcomes in cancer care using artificial intelligence. Their core product, Ataraxis Breast, is the world’s first AI-native prognostic/predictive platform for breast cancer, providing greater accuracy than standard of care. The company is on track to launch Ataraxis Breast for clinical use later this year and plans to expand its offerings to other cancer types.

Funding Round: Series A

Funding Amount: $20.4M

Date: 05-Mar-2025

Investors: AIX Ventures, Floating Point, Thiel Bio, Founders Fund, Bertelsmann Investments, Giant Ventures, Obvious Ventures, Mario Schlosser, Ryan Fukushima, OpenAI, DeepMind

Markets: AI, Healthtech

HQ: New York, New York, United States

Founded: 2022

Website: https://www.ataraxis.ai/

LinkedIn: https://www.linkedin.com/company/ataraxis-ai

Twitter: https://twitter.com/Ataraxis_AI

Instagram:

Facebook: https://www.facebook.com/61565635036304

Crunchbase: https://www.crunchbase.com/organization/ataraxis-4f24

Pitchbook: https://pitchbook.com/profiles/company/538847-38